Evidence map›Paper›PMID 36727127›Full record

ArticleEuropean heart journal. Case reports2023

Cardiac manifestations and clinical management of X-linked Emery-Dreifuss muscular dystrophy: a case series.

Niharika Kashyap, Anish Nikhanj, Luke R Gagnon, Basel Moukaskas, Zaeem A Siddiqi, Gavin Y Oudit

Open access · goldAbstract readCase Reports
In one paragraph

Article in European heart journal. Case reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Niharika KashyapDivision of Cardiology, Department of Medicine, University of Alberta, 8440 112 Street NW, Edmonton, Alberta T6G 2R7, Canada.
Anish NikhanjDivision of Cardiology, Department of Medicine, University of Alberta, 8440 112 Street NW, Edmonton, Alberta T6G 2R7, Canada.ORCID https://orcid.org/0000-0002-2247-4907
Luke R GagnonDivision of Cardiology, Department of Medicine, University of Alberta, 8440 112 Street NW, Edmonton, Alberta T6G 2R7, Canada.
Basel MoukaskasDivision of Cardiology, Department of Medicine, University of Alberta, 8440 112 Street NW, Edmonton, Alberta T6G 2R7, Canada.
Zaeem A SiddiqiDivision of Neurology, Department of Medicine, University of Alberta, 8440 112 Street NW, Edmonton, Alberta T6G 2R7, Canada.
Gavin Y OuditDivision of Cardiology, Department of Medicine, University of Alberta, 8440 112 Street NW, Edmonton, Alberta T6G 2R7, Canada.ORCID https://orcid.org/0000-0002-9154-9028
University of Alberta · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Heart disease is an under-recognized cause of morbidity and mortality in patients with Emery-Dreifuss muscular dystrophy (EDMD). Arrhythmias and conduction delays are highly prevalent and given the rarity of this disease the patient care process remains poorly defined. Case summary: This study closely followed four adult patients from the Neuromuscular Multidisciplinary Clinic (Alberta, Canada) that presented with X-linked recessive EDMD. Patients were assessed and managed on a case-by-case basis. Clinical status and cardiac function were assessed through clinical history, physical examination, and investigations (12-lead electrocardiogram, 24 hour Holter monitor, transthoracic echocardiogram, and plasma biomarkers). Conduction disease, requiring permanent pacemaker, was prevalent in all patients. With appropriate medical therapy over a median follow-up period five years the cardiac status was shown to have stabilized in all these patients. Discussion: We demonstrate the presentation of arrhythmias, conduction abnormalities, and chamber dilation in adult patients with X-linked EDMD. Cardiac medications and pacemaker therapy are shown to prevent adverse outcomes from these complications. Patients with EDMD are expected to develop heart disease early and prior to the development of an overt neuromuscular phenotype. These patients should be closely monitored in a multidisciplinary setting for effective management to improve their clinical outcomes.

Indexed as

ArrhythmiasCase seriesDilated cardiomyopathyEmery-Dreifuss muscular dystrophyPacemaker

Identifiers

PMID36727127
PMCPMC9879840
OpenAlexW4315641576

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.